The final pathogenetic steps in focal bone erosions in rheumatoid arthritis
- 1 November 2000
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 59, i72-i74
- https://doi.org/10.1136/ard.59.suppl_1.i72
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factorArthritis & Rheumatism, 2000
- Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandNature, 1999
- Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.Journal of Clinical Investigation, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro1Endocrinology, 1998
- TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival FactorThe Journal of Experimental Medicine, 1997
- TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T CellsJournal of Biological Chemistry, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- PARATHYROID HORMONE-RELATED PEPTIDE IN SYNOVIAL FLUID AND DISEASE ACTIVITY OF RHEUMATOID ARTHRITISRheumatology, 1995